doi: 10.1177/00359157760690S224.
Lipokinetic studies with gemfibrozil (CI-719)
- PMID: 190610
- PMCID: PMC1864040
- DOI: 10.1177/00359157760690S224
Item in Clipboard
Lipokinetic studies with gemfibrozil (CI-719)
Proc R Soc Med.
1976.
Abstract
Gemfibrozil (CI-719) has proved to be an effective agent in reducing the plasma triglyceride levels in experimental animals and in patients with endogenous hypertriglyceridaemia. We have confirmed these findings.
Similar articles
-
Effect of gemfibrozil on lipolysis in dogs in vivo.Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):107-8. doi: 10.1177/00359157760690S228. Proc R Soc Med. 1976. PMID: 1019148 Free PMC article. No abstract available.
-
Gemfibrozil: a new lipid lowering agent. Open forum.Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):115-20. doi: 10.1177/00359157760690S231. Proc R Soc Med. 1976. PMID: 1019151 Free PMC article. No abstract available.
-
The hypolipidaemic effect of gemfibrozil (CI-719) in laboratory animals.Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):6-10. doi: 10.1177/00359157760690S203. Proc R Soc Med. 1976. PMID: 828263 Free PMC article. No abstract available.
-
Metabolism of the plasma lipoproteins.Sci Basis Med Annu Rev. 1972:118-44. Sci Basis Med Annu Rev. 1972. PMID: 4344060 Review. No abstract available.
-
Dietary regulation of plasma lipoprotein metabolism in humans.Prog Biochem Pharmacol. 1983;19:110-22. Prog Biochem Pharmacol. 1983. PMID: 6338520 Review. No abstract available.
Cited by
-
Lowering of triglycerides by gemfibrozil affects neither the glucoregulatory nor antilipolytic effect of insulin in type 2 (non-insulin-dependent) diabetic patients.Diabetologia. 1993 Feb;36(2):161-9. doi: 10.1007/BF00400699. Diabetologia. 1993. PMID: 8458531 Clinical Trial.
-
Gemfibrozil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in dyslipidaemia.Drugs. 1988 Sep;36(3):314-39. doi: 10.2165/00003495-198836030-00004. Drugs. 1988. PMID: 3056692 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources